Tuberculosis is one of the most common infections in Zambian adults and children infected with HIV. In Africa, cutaneous hypersensitivity reactions attributed to thiacetazone during treatment of tuberculosis in adults infected with HIV
children infected with HIV and three (2%) of 149 children not infected with H1V. These skin reactions occurred after a period of treatment ranging between two and four weeks among 14 children receiving the HST (isoniazid, streptomycin, thiacetazone) regimen and eight children receiving the HSTR (isoniazid, streptomycin, thiacetazone, rifampicin) regimen. Twelve (55%) of the 22 children who reacted adversely to treatment developed the Stevens-Johnson syndrome. All 12 of these children with the Stevens-Johnson syndrome were infected with HIV. The mortality among these children who developed the StevensJohnson syndrome was 91% (11 of 12 died within three days of the onset of the reaction). No further reactions were observed in the 11 children who recovered from the cutaneous hypersensitivity reactions after thiacetazone was discontinued over a period of six months of further treatment for tuberculosis. The results of this study were in part responsible for the recommendations put forward by the World Health Organisation to avoid the use of thiacetazone in the treatment oftuberculosis in children infected with HIV.
(Arch Dis Child 1993; 68: [665] [666] [667] [668] The relation between the HIV infection and tuberculosis in Africa has been well documented. ' TREATMENT 
REGIMEN
In accordance with national guidelines at the time, treatment of localised tuberculosis was initiated with the HST regimen (isoniazid 10-15 mg/kg/day by mouth, streptomycin mg/kg/day intramuscularly for two months, thiacetazone 5-8 mg/kg/day by mouth) for a minimum period of 12 months. In disseminated forms of the disease (tuberculous meningitis, miliary tuberculosis at initiation, and in patients with localised disease where no response to treatment was seen after one month of HST, the HSTR regimen (HST plus rifampicin 15-20 mg/ kg/day) was used for a minimum period of six months.
HIV-I SEROLOGY HIV-I serology was determined using two enzyme linked immunosorbant assays (ELISAs), Welcozyme (Wellcome Diagnostics, Dartford, Oxford) and the antiglobulin recombinant ELISA (DuPont de Nemours, Wilmington, Delaware, USA). Those samples postive by the two ELISAs were subjected to western blot analysis. HIV-II has not been reported to be important in Zambia. In children less than 18 months of age the HIV serology was repeated when the child was 18 months old.
DEFINITION OF HYPERSENITIVITY
Cutaneous hypersensitivity reactions to treatment for tuberculosis were defined as a skin rash appearing after the start of treatment with or without mucosal involvement or the presence of itching, and for those who survived, the disappearance ofthe rash on withdrawal ofthiacetazone. Lesions were classified as maculopapular, target, or mucosal, and the presence of desquamation or bullae was noted. The clinical disorder was classified as Stevens-Johnson syndrome when the patient was systemically ill with the mucosal surfaces affected (mouth, eye, urinary tract, and vagina) with extensive skin disease and the presence of builae or target lesions.
MANAGEMENT OF SIDE EFFECTS
When side effects were noted all drugs were stopped and prednisolone and chlorpheniramine were prescribed at the discretion of the doctor in charge. In those patients who recovered, thiacetazone was discontinued on the recommencement of treatment for tuberculosis, and replaced by rifampcin in those receiving the HST regimen and by pyrizinamide in those 
